---
figid: PMC6721552__cancers-11-01185-g003
figtitle: Simplified overview of the MAPK and PI3K pathway
organisms:
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Homo sapiens
- Mus musculus
- Diaporthe sclerotioides
- Human gammaherpesvirus 4
organisms_ner:
- Mus musculus
- Homo sapiens
- Bos taurus
- Oryctolagus cuniculus
- Capra hircus
- Drosophila melanogaster
pmcid: PMC6721552
filename: cancers-11-01185-g003.jpg
figlink: /pmc/articles/PMC6721552/figure/cancers-11-01185-f003/
number: F3
caption: A simplified overview of the MAPK and PI3K pathway. Activation of pathways
  can occur by growth factors activating the RTKs or overexpression of RTKs. Mutations
  in the signaling pathway, in tumor suppressor genes, and fusion RTKs, can cause
  constitutive activation. RTK, receptor tyrosine kinase. MAPK, mitogen-activated
  protein kinase. PI3K, phosphatidylinositide 3-kinase. NF1, neurofibromin 1. PTEN,
  phosphatase and tensin homolog. TSC1/2, tuberous sclerosis complex 1/2. mTOR, mammalian
  target of rapamycin. VEGFR, vascular endothelial growth factor receptor. PDGFR-α,
  -β, platelet-derived growth factor receptor-α, -β, FGFR-1-3.
papertitle: Targeted Treatment Options of Recurrent Radioactive Iodine Refractory
  Hürthle Cell Cancer.
reftext: Mehtap Derya Aydemirli, et al. Cancers (Basel). 2019 Aug;11(8):1185.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9454265
figid_alias: PMC6721552__F3
figtype: Figure
redirect_from: /figures/PMC6721552__F3
ndex: 088d39e6-def8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6721552__cancers-11-01185-g003.html
  '@type': Dataset
  description: A simplified overview of the MAPK and PI3K pathway. Activation of pathways
    can occur by growth factors activating the RTKs or overexpression of RTKs. Mutations
    in the signaling pathway, in tumor suppressor genes, and fusion RTKs, can cause
    constitutive activation. RTK, receptor tyrosine kinase. MAPK, mitogen-activated
    protein kinase. PI3K, phosphatidylinositide 3-kinase. NF1, neurofibromin 1. PTEN,
    phosphatase and tensin homolog. TSC1/2, tuberous sclerosis complex 1/2. mTOR,
    mammalian target of rapamycin. VEGFR, vascular endothelial growth factor receptor.
    PDGFR-α, -β, platelet-derived growth factor receptor-α, -β, FGFR-1-3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Nf1
  - Zhx2
  - Pik3r1
  - Pten
  - Akt1
  - Tsc2
  - Tsc1
  - Ephb2
  - Mapk1
  - Mtor
  - Mdk
  - KRAS
  - HRAS
  - NRAS
  - NF1
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PTEN
  - AKT1
  - AKT2
  - AKT3
  - TSC2
  - TSC1
  - CCL26
  - EPHB2
  - MAPK1
  - MAPK3
  - MTOR
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - Tie
  - Ras85D
  - InR
  - Ras64B
  - Raf
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - gig
  - Erk7
  - rl
  - Tor
  - Dsor1
  - Mtk
  - Cancer
---
